BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Net income 2016–2025
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.3MFY2025 · since FY2016: -$5.0M → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | +11.3% |
| FY2024 | -$11.6M | +32.4% |
| FY2023 | -$17.2M | +29.2% |
| FY2022 | -$24.3M | +0.7% |
| FY2021 | -$24.5M | +23.1% |
| FY2020 | -$31.8M | -36.8% |
| FY2019 | -$23.3M | -66.7% |
| FY2018 | -$13.9M | -181.7% |
| FY2017 | -$5.0M | +0.6% |
| FY2016 | -$5.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCLI financial trends
BCLI RevenueBCLI Net marginBCLI Gross profitBCLI Gross marginBCLI Operating incomeBCLI Operating marginBCLI Operating cash flowBCLI Free cash flowBCLI Capital expendituresBCLI Return on equityBCLI Stock buybacksBCLI Dividends paidBCLI Total assetsBCLI Total liabilitiesBCLI Shareholders’ equityBCLI overview →